Hepatology Search
Hepatology Hepatology

Conference Reports

The International Liver Congress™ 2019 (ILC 2019)
Vienna, Austria
10 April 2019 - 14 April 2019
12th IDF-WPR Congress & 10th AASD Scientific Meeting
Kuala Lumpur
22 November 2018 - 25 November 2018
2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
San Francisco, California, US
18 January 2018 - 20 January 2018
Asia Pacific Digestive Week 2017 (APDW 2017)
Hong Kong
23 September 2017 - 26 September 2017
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Shanghai, China
15 February 2017 - 19 February 2017
Asia Pacific Digestive Week 2016 (APDW 2016)
Kobe, Japan
02 November 2016 - 05 November 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Fatty liver on the rise among young adults
Audrey Abella, 30 Apr 2019
Nonalcoholic fatty liver disease (NAFLD, or steatosis) was prevalent in a substantial number of young adults, suggesting an imminent public health crisis if left undiagnosed and untreated, according to data from a large UK trial presented at ILC 2019.
Obeticholic acid: A first for NASH?
Roshini Claire Anthony, 02 May 2019

Patients with non-alcoholic steatohepatitis (NASH) may benefit from treatment with a 25 mg/day dose of obeticholic acid, according to the interim analysis of the phase III REGENERATE* study presented at the International Liver Congress™ (ILC 2019).

NAFLD/NASH progression to advanced liver disease tied to elevated mortality risk
Roshini Claire Anthony, 29 Apr 2019

Adults with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) who progress to advanced liver disease have an elevated risk of mortality compared with non-progressors, according to two separate studies conducted in Germany and France and presented at the International Liver Congress™ (ILC 2019).

Rising risk of NAFLD-related mortality in HIV+ individuals
Roshini Claire Anthony, 07 May 2019

The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress™ (ILC 2019).